Dr. Ruder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
79-01 Broadway
Room A1-19
Elmhurst, NY 11373
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2020
McGovern Medical School at UTHealthClass of 2017
University of Texas HoustonMD
Certifications & Licensure
NY State Medical License 2020 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Antibody-drug conjugates in urothelial carcinoma: current status and future.Samuel Ruder, Juana Martinez, Jessica Palmer, Abdul Baseet Arham, Scott T Tagawa
Current Opinion in Urology. 2025-01-23 - Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death.Yi Ding, Ping Bu, Binara Assylbekova, Samuel Ruder, Brian Miles
Human Pathology. 2024-02-01 - 35 citationsProgrammed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.Scot A. Niglio, Rachel Jia, Jiayi Ji, Samuel Ruder, Vaibhav G. Patel
European Urology. 2019-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
